STOCK TITAN

Nu-Med Plus (NUMD) Stock Price, News & Analysis

NUMD OTC
Published by Stock Titan Data refreshed

Price Move History

Daily moves over 5%
39 60 sessions, October 13, 2025 to October 20, 2026
Largest daily move
+68% close of April 29, 2026
1-year change
-76% closing prices, October 13, 2025 to October 20, 2026
1-month change
-68.7% closing prices, August 28, 2026 to October 20, 2026

Company Description

Nu-Med Plus (OTC: NUMD) is classified in the medical devices industry within the Healthcare sector and carries a market capitalization of $601.5K.

NUMD declined 76.0% in the 12 months to October 20, 2026. The last closing price was $0.0072.

For FY2025, Nu-Med Plus reported diluted earnings per share of $0.00.

This page collects what Stock Titan holds for NUMD, including price data, latest news, SEC filings, financial highlights, and short interest trends.

Stock Performance

$0.0072
No recent trading
Last close: October 20, 2026
-76%
1 year to October 20, 2026
$601.5K

Nu-Med Plus (NUMD) closed at $0.0072 on October 20, 2026. In the 12 months to October 20, 2026, the price lost 76.0%.

See what a $1,000 investment in NUMD would be worth today

Average down calculator for NUMD

NUMD Metrics & Rankings

Market Cap
$601.5K
View ranking

Price returns through October 20, 2026. Month and year figures include the first trading day. Ranking links may use different dates.

Latest News

Nu-Med Plus has 1 recent news article. Of the recent coverage, 1 article coincided with positive price movement and 0 with negative movement. Key topics include acquisition. View all NUMD news →

Financial Highlights

—
Revenue (FY2025)
—
Net Income (FY2025)
—
Operating Cash Flow

Upcoming Events

No upcoming events scheduled for NUMD.

Short Interest History

Last 12 Months

Short interest in Nu-Med Plus (NUMD) currently stands at 35.7 thousand shares, representing 0.1% of the float.

Days to Cover History

Last 12 Months

Days to cover for Nu-Med Plus (NUMD) currently stands at 1.0 days, down 86.5% from the previous period. The ratio is the reported short interest divided by the average daily trading volume. Since November 2025, the figure has decreased by 31%. Across the settlements charted above, it has ranged from 1.0 to 1000.0 days.

NUMD Company Profile & Sector Positioning

Nu-Med Plus (NUMD) operates in the Medical Devices industry within the broader Healthcare sector and is listed on the OTC.

Investors comparing NUMD often look at related companies in the same sector, including Ludwig Enterprises (LUDG), Verisante Technology Inc (VRSEF), Odyssey Health Inc (ODYY), Electromedical Tech Inc (EMED), and Biotricity Inc (BTCY). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate NUMD's relative position within its industry.

Frequently Asked Questions

Nu-Med Plus (NUMD) has no recent trading. Its last close was $0.0072 on October 20, 2026.

The market cap of Nu-Med Plus (NUMD) is approximately $601.5K. Learn more about what market capitalization means .

The diluted earnings per share (EPS) of Nu-Med Plus (NUMD) is $0.00 for FY2025, its most recent completed fiscal year. Learn more about EPS .

The current ratio of Nu-Med Plus (NUMD), current assets divided by current liabilities, was 0.03 at the end of FY2025, its most recent completed fiscal year. Learn about liquidity ratios.